Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
NCT01912560
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Hypercholesterolemia
Hypertriglyceridemia
Interventions
DRUG:
CAT-2003
DRUG:
Placebo
DRUG:
Statin
Sponsor
Catabasis Pharmaceuticals